Can't help but wonder where the funding came from:
http://www.theguardian.com/environment/2015/feb/21/climate-c...
Sponsor: Merck Sharp & Dohme Corp
Official Title: A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women
Health Authority: United States: Food and Drug Administration